Seelos Therapeutics Inc (SEEL)
1.201
-0.02
(-1.59%)
USD |
NASDAQ |
May 31, 16:00
1.20
0.00 (0.00%)
After-Hours: 20:00
Seelos Therapeutics Accounts Payable (Quarterly): 15.27M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 15.27M |
December 31, 2023 | 16.40M |
September 30, 2023 | 9.32M |
June 30, 2023 | 6.437M |
March 31, 2023 | 5.963M |
December 31, 2022 | 3.626M |
September 30, 2022 | 5.952M |
June 30, 2022 | 2.306M |
March 31, 2022 | 2.127M |
December 31, 2021 | 1.693M |
September 30, 2021 | 3.401M |
June 30, 2021 | 1.038M |
March 31, 2021 | 1.628M |
December 31, 2020 | 1.887M |
September 30, 2020 | 0.355M |
June 30, 2020 | 0.63M |
March 31, 2020 | 3.281M |
December 31, 2019 | 0.796M |
September 30, 2019 | 1.848M |
June 30, 2019 | 1.025M |
March 31, 2019 | 2.421M |
December 31, 2018 | 0.235M |
September 30, 2018 | 0.322M |
June 30, 2018 | 1.054M |
March 31, 2018 | 0.344M |
Date | Value |
---|---|
December 31, 2017 | 0.058M |
September 30, 2017 | 0.262M |
June 30, 2017 | 0.14M |
March 31, 2017 | 0.485M |
December 31, 2016 | 0.763M |
September 30, 2016 | 1.434M |
June 30, 2016 | 1.601M |
March 31, 2016 | 1.096M |
December 31, 2015 | 1.58M |
September 30, 2015 | 0.417M |
June 30, 2015 | 0.446M |
March 31, 2015 | 0.88M |
December 31, 2014 | 0.86M |
September 30, 2014 | 1.221M |
June 30, 2014 | 1.128M |
March 31, 2014 | 0.992M |
December 31, 2013 | 0.926M |
September 30, 2013 | 0.615M |
June 30, 2013 | 1.458M |
March 31, 2013 | 1.85M |
December 31, 2012 | 2.277M |
September 30, 2012 | 2.034M |
June 30, 2012 | 0.6948M |
March 31, 2012 | 0.7375M |
December 31, 2011 | 1.052M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.355M
Minimum
Sep 2020
16.40M
Maximum
Dec 2023
4.249M
Average
2.216M
Median
Accounts Payable (Quarterly) Benchmarks
180 Life Sciences Corp | 1.784M |
Johnson & Johnson | 8.174B |
Acurx Pharmaceuticals Inc | -- |
NovaBay Pharmaceuticals Inc | 1.117M |
Palatin Technologies Inc | 3.443M |